Replies to post #320304 on Innovation Pharmaceuticals Inc (IPIX)

[JTORENCE]

maxinvest have no idea, but you brought up a good point. Good question to ask the pumpers on that board. I'll bet they have no friggin idea of what you are talking about.imo

[KMBJN]

Aviptadil isn't much of an antiviral, IMO. It's more of a hormone / immunomodulator, that works mainly by increasing lung surfactant (including some surfactant proteins with defensin like activity).

https://www.biorxiv.org/content/10.1101/2020.07.25.220806v2.full

Showed in Vero and human lung cells that VIP/aviptadil only reduced viral load by ~40%, so there is no IC50 if the definition if 50% reduction of viral load.

They had very impressive EIND/EA data thus far, though, and pretty good safety.

[thefamilyman]

I do not know about the science behind Aviptadil. But their Market Cap is up ~$1.1 Billion from their 52 week low. If that were to happen to IPIX, it would equate to about a $3.00 price per share.

You said,

I only see Aviptadil as our closest competitor so far. Does anyone know if their SI was ever provided or is known. There is 0 doubt in my mind we are better but their drug is also effective and is closer to finish line so naturally i want LEO to 'move it' even thou i know he is doing everything he can.....